Quantitative analysis for Parabilis Medicines Inc. Common Stock (PBLS) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Hold (54.0) (grade C). 25 signals analyzed (21 differentiated alt-data).
PBLS stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-06-08 | $20.00 | $20.00 | $20.00 |
| 2026-06-16 | $26.72 | $24.91 | $26.59 |
| 2026-06-25 | $27.99 | $25.70 | $26.36 |
| 2026-07-06 | $30.00 | $28.15 | $29.20 |
| 2026-07-14 | $31.40 | $28.55 | $31.15 |
| 2026-07-22 | $31.15 | $29.35 | $30.81 |
| 2026-07-30 | $33.05 | $30.83 | $32.28 |
| 2026-08-07 | $36.50 | $34.21 | $34.98 |
| 2026-08-17 | $38.83 | $36.41 | $37.81 |
| 2026-08-25 | $39.90 | $38.37 | $39.23 |
| 2026-09-02 | $41.14 | $38.31 | $40.11 |
| 2026-09-11 | $37.74 | $36.44 | $36.88 |
How Parabilis Medicines Inc. Common Stock stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| AZN | AstraZeneca PLC | $290.7B | — |
| NVS | Novartis AG | $287.1B | — |
| NVO | Novo Nordisk A/S | $200.3B | — |
| SNY | Sanofi | $107.6B | — |
View all Health Care stocks by valuation and signals →
Parabilis Medicines Inc. Common Stock (PBLS) scores Hold (54.0), and the composite conceals a 59-point disagreement between its dimensions. It is strongest on analyst consensus at 86, and weakest on competitive moat at 27. A stock can carry analyst consensus that high while competitive moat sits at 27; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 86 |
| technicals | 56 |
| competitive moat | 27 |
StoQuant analyzes 25 signals (21 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Parabilis Medicines Inc. Common Stock (PBLS): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/PBLS"><img src="https://stoquant.com/badge/PBLS.svg" alt="Parabilis Medicines Inc. Common Stock (PBLS) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.